Compare Becton Dickinson and Co (BDX) vs Honest Company Inc (HNST) Price & Performance

BDX trades at $179.63, up 1.57% with a bullish technical outlook supported by moving averages. The company reported strong Q3 2026 earnings, beating estimates with $3.23 EPS versus $3.14 expected, and raised full-year guidance. Revenue growth remains steady at 4.4% FX-neutral, though margins face pressure from tariffs. Analysts maintain a mixed consensus with 47% buy ratings and a $183 price target, suggesting modest upside from current levels.

The stock presents a balanced opportunity with solid fundamentals and dividend stability, but faces headwinds from margin compression and competitive pressures. Near-term catalysts include continued execution on growth initiatives, while risks include tariff impacts and healthcare regulatory changes. The current valuation at 31.39 P/E appears fair given growth prospects.

HNST trades at $5.23, down 4.21% today, with a bullish technical signal from moving averages but overbought RSI readings. The company shows mixed fundamentals with Q2 2026 EPS beating estimates at $0.04 versus $0.00926 expected, though revenue declined to $342M in 2026 with a net loss of $12M. Operating cash flow improved to $57M in 2026, and strategic exits are showing progress according to recent company updates.

The outlook remains cautious due to persistent net losses and margin pressure, offset by improving cash flow and recent earnings beats. Key risks include sustained profitability challenges and competitive pressures in personal care markets, while analyst sentiment is mixed with 30% buy ratings amid ongoing turnaround efforts.